🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Liam Il‐Young Chung

Northwestern University

ORCID: 0000-0001-6541-793X
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.463Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer

Annals of Transplantation(2023)10.12659/aot.941301
Top 41%
0.463DataRank
Top 41%8 citations

Maria Jose Aguilera Chuchuca, Jisang Yu, Liam Il‐Young Chung, Ankit Bharat, Young Kwang Chae +1 more

Papers

Driven by 12 papers — median percentile 59. Top paper: “Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer”.

Survival Outcomes After Double-Lung Transplantation for Refractory Lung-Limited Cancers and Incidence of Post-Transplant Lung Cancer

Annals of Transplantation(2023)10.12659/aot.941301
Top 41%
0.463DataRank
Top 41%8 citations

Maria Jose Aguilera Chuchuca, Jisang Yu, Liam Il‐Young Chung, Ankit Bharat, Young Kwang Chae +1 more

Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) SWOG S1609: the desmoid tumors

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009128
N/A
0.380DataRank · unranked
9 citations

Megan Othus, Sandip Pravin Patel, Benjamin Powers, Chung-Tsen Hsueh, Rangaswamy Govindarajan +11 more

Current and future role of double-lung transplantation for bilateral lung cancer

Transplantation Reviews(2023)10.1016/j.trre.2023.100772
N/A
0.373DataRank · unranked
11 citations

Samuel Schellenberg, Liam Il‐Young Chung, Ankit Bharat, Young Kwang Chae, Jeeyeon Lee

Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)

Therapeutic Advances in Medical Oncology(2024)10.1177/17588359241293401
N/A
0.104DataRank · unranked
1 citations

Megan Othus, Sandip Pravin Patel, David E. Gerber, Tawee Tanvetyanon, Hye Sung Kim +10 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11516
N/A
0DataRank · unranked
0 citations

Megan Othus, Sandip Pravin Patel, Benjamin Powers, Chung-Tsen Hsueh, Rangaswamy Govindarajan +10 more

SWOG/NCI Phase II Dual Anti–CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0606
N/A
0DataRank · unranked
11 citations

Megan Othus, Sandip Pravin Patel, Kelly J. Wilkinson, Emily M. Whitman-Purves, Jayanthi Lea +21 more

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1957
N/A
0DataRank · unranked
6 citations

Lucy Corthell, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Hye Sung Kim +10 more

A phase II basket trial of dual anti‐CTLA‐4 and anti‐PD‐1 blockade in rare tumors (DART) SWOG S1609: durable responses and delayed pseudoprogression in small cell carcinoma of the ovary, hypercalcemic type cohort

Cancer Communications(2025)10.1002/cac2.70020
N/A
0DataRank · unranked
3 citations

Megan Othus, Sandip Pravin Patel, Raid Aljumaily, Khine Z. Win, Tanya Pejovic +12 more

QVT Score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy

medRxiv(2025)10.1101/2025.09.08.25335020
N/A
0DataRank · unranked
0 citations

Vamsidhar Velcheti, Kai Zhang, Amogh Hiremath, Liam Il‐Young Chung, Omid Haji Maghsoudi +15 more

A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation

Transplant International(2023)10.3389/ti.2023.11552
N/A
0DataRank · unranked
3 citations

Andrew Won Jun Yang, Liam Il‐Young Chung, Jisang Yu, Yunjoo Lee, Hye Sung Kim +5 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The vulvar cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5517
N/A
0DataRank · unranked
4 citations

Megan Othus, Sandip Pravin Patel, Robert P. Edwards, Jennifer Scalici, Liam Il‐Young Chung +8 more

A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with refractory gallbladder cancer (cohort 48).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e16330
N/A
0DataRank · unranked
0 citations

Elizabeth Guadarrama, Young Kwang Chae, Chih‐Yi Liao, Anup Kasi, Grace R. Tarabay +12 more